
Age is one of the most important zzso factors in zzso patients, but no standard treatment has been established for elderly patients with this zzso We therefore conducted a retrospective cohort study to evaluate treatment regimens and outcomes in elderly zzso zzso The study population consisted of 79 zzso patients aged zzso 76 years zzso age zzso years; 34 men and 45 zzso The median zzso zzso performance status zzso score was zzso zzso procedures were classified as biopsy zzso patients, zzso zzso zzso % zzso of the tumor (21 patients, zzso zzso and zzso 95 % zzso of the tumor zzso patients, zzso zzso zzso patients zzso zzso received zzso and 45 patients zzso zzso received zzso The median overall zzso survival time was zzso months, and the median overall survival time was zzso zzso Patients aged zzso 78 years were significantly less likely to receive zzso zzso zzso zzso Patients with a zzso zzso score of zzso 60 were significantly more likely to receive maintenance chemotherapy zzso zzso zzso zzso analyses identified two independent zzso factors: zzso zzso score zzso 60 zzso ratio zzso zzso zzso 95 % confidence zzso zzso zzso p zzso zzso and zzso therapy zzso zzso zzso 95 % zzso zzso p zzso zzso findings of this study suggest that zzso zzso score is an important zzso factor for zzso patients aged zzso 76 years, and that these patients may benefit from zzso zzso 

